Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Intended consumers
Intended consumers
Commercial
Products 81 to 90 of 150
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Hydrogen Sulfide Sourced Fuels
by
Ginkgo Bioworks
Biotech components:
Bacteria
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/02 11:54 (7 years ago)
Known funding amount:
6,438,793 USD
Funding types:
Government
Industry:
Energy
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Impossible Burger
by
Impossible Foods
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
189,000,000 USD
Funding types:
Venture Capital
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Food
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Injectable Alpha 1-antitrypsin
by
Halozyme
Biotech components:
Enzyme
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
200,000,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
HALO
(NASDAQ)
Value chain stage:
Finished Product
Insulin-producing bacteria
by
Venter Institute
Biotech components:
Bacteria
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/01 09:50 (7 years ago)
Known funding amount:
50,000 USD
Funding types:
Foundation
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
L-Methionine
by
Metabolic Explorer SA
Biotech components:
Enzyme
Business models:
B2B
Country of production:
France
Country of distribution:
France
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Feed
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
METEX
(EPA)
Value chain stage:
Input
PCR-produced linear DNA
by
Applied DNA Sciences
+
LineaRx
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2019/01/30 11:54 (6 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Science
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Research
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Platform
Laundry Detergent Enzyme
by
Novozymes
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Denmark
Country of distribution:
Denmark
+
China
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/08 14:50 (7 years ago)
Known funding amount:
12,880,000 DKK
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
Web search
Trading symbol:
NZYM-B
(CPH)
Value chain stage:
Input
Low Saturated Fat Canola Oil
by
Catalyxt
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/09/28 15:00 (7 years ago)
Known funding amount:
608,825,000 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Plant
Production process:
Open Release
Source:
Web search
Trading symbol:
CLXT
(NASDAQ)
Value chain stage:
Finished Product
Luminase PB-100
by
BASF
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
Germany
+
USA
+
Brazil
+
China
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
85,090,000 EUR
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BASF SE
(ETR)
Value chain stage:
Input
Malonic Acid
by
Lygos, Inc (Advanced Biofuels Process Demonstration Unit)
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
13,100,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
1
…
4
5
6
7
8
9
10
11
12
13
…
15
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
